Keyphrases
Solid Cancer
100%
Genetic Profile
100%
Tumor Genomics
100%
Thromboembolic Risk
100%
Arterial Thromboembolism
100%
Genetic Modification
27%
STK11
18%
Cox Proportional Hazards Regression
9%
Retrospective Cohort Study
9%
Electronic Medical Records
9%
Cancer Types
9%
Tumor Subtype
9%
Myocardial Infarction
9%
Ischemic Stroke
9%
Patients with Cancer
9%
Tumor Suppressor Gene
9%
Solid Tumors
9%
KRAS Oncogene
9%
Clinical Covariates
9%
Metastatic Disease
9%
Cause-specific
9%
High-risk Population
9%
Coronary Revascularization
9%
Cancer-specific
9%
Target Validation
9%
Cancer Targeting
9%
Tumor Genetics
9%
Mutation Profiling
9%
Impact of Cancer
9%
Blood Control
9%
Memorials
9%
Tumor Profiling
9%
Limb Revascularization
9%
Peripheral Arterial Occlusion
9%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
100%
Arterial Thromboembolism
100%
Cancer
18%
Electronic Patient Record
9%
Metastatic Carcinoma
9%
Cancer Types
9%
Somatics
9%
Gene Mutation
9%
Myocardial Infarction
9%
Revascularization
9%
Limb
9%
Retrospective Cohort Study
9%
Proportional Hazards Model
9%
Brain Ischemia
9%
Tumor Suppressor Gene
9%
Solid Malignant Neoplasm
9%
Oncogene
9%
High Risk Population
9%
Heart Muscle Revascularization
9%
Artery Occlusion
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Malignant Neoplasm
100%
Arterial Thromboembolism
100%
Cohort Study
9%
Heart Infarction
9%
Brain Ischemia
9%
Solid Malignant Neoplasm
9%
Metastasis
9%
Tumor Suppressor Protein
9%
Artery Occlusion
9%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
KRAS
50%
STK11
50%
Cohort Study
25%
Gene Mutation
25%
Tumor Suppressor Gene
25%
Oncogene
25%
High Risk Population
25%
Electronic Medical Record
25%